Author:
Moawad Nash S.,Gonzalez Alejandro M.,Artazcoz Santiago
Publisher
Springer International Publishing
Reference7 articles.
1. Elkholi DGE, Nagy HM. Unexplained postmenopausal uterine bleeding from atrophic endometrium: histopathological and hormonal studies. Middle East Fertil Soc J. 2015;20(4):262–70.
2. Sivridis E, Giatromanolaki A. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma. J Clin Pathol. 2004;57(8):840–4.
3. McGonigle KF, Shaw SL, Vasilev SA, Odom-Maryon T, Roy S, Simpson JF. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy. Am J Obstet Gynecol. 1998;178(6):1145–50.
4. Kalampokas T, Sofoudis C, Anastasopoulos C, Boutas I, Melloy S, Kondi-Pafiti A, Kalampokas E, Botsis D, Salakos N. Effect of tamoxifen on postmenopausal endometrium. Eur J Gynaecol Oncol. 2013;34(4):325–8.
5. Ferrazzi E, Torri V, Zannoni E, Filiberto S, Dordoni D. Sonographic endometrial thickness: a useful test to predict atrophy in patients with postmenopausal bleeding. An Italian multicenter study. Ultrasound Obstet Gynecol. 1996;7:315–21.